GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Readout] SELECT: MACE HR 0.80, and the absolute numbers people skip — 14 comments in the full submission. View in context.
95
c/trialwatch·submitted 4 days ago by u/heart_rate_bump

[Readout] SELECT: MACE HR 0.80, and the absolute numbers people skip

Readoutbranch of 5 comments

Right, the TRIUMPH question again, but with numbers this time. I have 8 data points over 28 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign. The thing I would flag for anyone new: the effect I am describing…

Read the full submission and all 14 comments →

This branch

5 comments, started 2 days ago
u/yara_bakken3 points·2 days ago

You have restated the marketing copy. What is the actual substance here.

replysharereportpermalink
u/careful_gradient_again1 point·2 days ago

the relative risk reduction in headlines is not the whole story

replysharereportpermalink
u/forest_plot_fionastats1 point·2 days ago

the relative risk reduction in headlines is not the whole story

Adding to this: hazard ratio is doing more work than the comment implies.

replysharereportpermalink
u/ines_castellanos1 point·1 days ago

absolute risk reduction, not relative risk reduction, that is how you decide

replysharereportpermalink
[deleted]1 point·1 days ago

[deleted]

replysharereportpermalink

← back to the whole thread

About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/trialwatch
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/trialwatch_theou/forest_plot_fionau/hazard_ratio_halu/renal_outcomes_r
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →